Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 2
2006 2
2007 2
2008 1
2009 1
2010 1
2011 4
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Protein delivery using engineered virus-like particles.
Kaczmarczyk SJ, Sitaraman K, Young HA, Hughes SH, Chatterjee DK. Kaczmarczyk SJ, et al. Among authors: chatterjee dk. Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):16998-7003. doi: 10.1073/pnas.1101874108. Epub 2011 Sep 26. Proc Natl Acad Sci U S A. 2011. PMID: 21949376 Free PMC article.
A novel cell-free protein synthesis system.
Sitaraman K, Esposito D, Klarmann G, Le Grice SF, Hartley JL, Chatterjee DK. Sitaraman K, et al. Among authors: chatterjee dk. J Biotechnol. 2004 Jun 10;110(3):257-63. doi: 10.1016/j.jbiotec.2004.02.014. J Biotechnol. 2004. PMID: 15163516
Recombinant protein quality evaluation: proposal for a minimal information standard.
Buckle AM, Bate MA, Androulakis S, Cinquanta M, Basquin J, Bonneau F, Chatterjee DK, Cittaro D, Gräslund S, Gruszka A, Page R, Suppmann S, Wheeler JX, Agostini D, Taussig M, Taylor CF, Bottomley SP, Villaverde A, de Marco A. Buckle AM, et al. Among authors: chatterjee dk. Stand Genomic Sci. 2011 Nov 30;5(2):195-7. doi: 10.4056/sigs.1834511. Epub 2011 Nov 22. Stand Genomic Sci. 2011. PMID: 22180821 Free PMC article. No abstract available.
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Narayan P, Prowell TM, Gao JJ, Fernandes LL, Li E, Jiang X, Qiu J, Fan J, Song P, Yu J, Zhang X, King-Kallimanis BL, Chen W, Ricks TK, Gong Y, Wang X, Windsor K, Rhieu SY, Geiser G, Banerjee A, Chen X, Reyes Turcu F, Chatterjee DK, Pathak A, Seidman J, Ghosh S, Philip R, Goldberg KB, Kluetz PG, Tang S, Amiri-Kordestani L, Theoret MR, Pazdur R, Beaver JA. Narayan P, et al. Among authors: chatterjee dk. Clin Cancer Res. 2021 Apr 1;27(7):1842-1849. doi: 10.1158/1078-0432.CCR-20-3652. Epub 2020 Nov 9. Clin Cancer Res. 2021. PMID: 33168657 Free PMC article. Clinical Trial.
17 results